Moderna is working on a vaccine targeting the Omicron variant for 2022.[1] The mRNA vaccine technology is "agile". There's a workflow from sequencing a virus to generating a candidate vaccine. It only took two days to generate the original COVID-19 vaccine. It's the clinical testing in small, then large groups that's the time consuming part. Also, the inhaled vaccines are entering clinical testing.[2] It's not like w…
> The mRNA vaccine technology is "agile". Yes and this means governments can quickly adapt to new variants by reformulating the vaccine, dumping old stock by "donating" it to developing nations, or dumping it, and buying new stock from big pharma. Since developing nations will always have far lower vaccination rates than first world countries, the virus will continue to mutate and proliferate outside of America and E…
A primary complaint is that “rich nations” hoard vaccines. doesn’t this exacerbate this?